Bladder Cancer, Version 2.2016 Featured Updates to the NCCN Guidelines Academic Article Article uri icon

Overview

MeSH Major

  • Cystadenocarcinoma
  • Prostatic Neoplasms

abstract

  • These NCCN Guidelines Insights discuss the major recent updates to the NCCN Guidelines for Bladder Cancer based on the review of the evidence in conjunction with the expert opinion of the panel. Recent updates include (1) refining the recommendation of intravesical bacillus Calmette-GuĂ©rin, (2) strengthening the recommendations for perioperative systemic chemotherapy, and (3) incorporating immunotherapy into second-line therapy for locally advanced or metastatic disease. These NCCN Guidelines Insights further discuss factors that affect integration of these recommendations into clinical practice.

authors

publication date

  • October 2016

Research

keywords

  • Academic Article

Identity

PubMed ID

  • 27697976

Additional Document Info

start page

  • 1213

end page

  • 1224

volume

  • 14

number

  • 10